News & Articles

The partnership with Primer Design aims to distribute the Genesig CE-IVD & FDA-EUA COVID-19 qPCR kit to Europe and the U.S.

The RAPIDPoint 500e blood gas analyzer aims to meet the unprecedented demand for blood gas testing in coronavirus patients

OPENCORONA consortium awarded €3 million funding by Horizon 2020 to support emergency research and development against the COVID-19 outbreak

The Abbott ID NOW™ COVID-19 test aims to bring rapid testing to the front lines of the global pandemic

These are some of the first antibody detection tests to be CE marked in Europe and available for COVID-19 testing

This clinical trial aims to test the effects of potential drug treatments for patients with the novel coronavirus

The Xpert Xpress SARS-CoV-2 test is designed for the qualitative detection of the virus causing COVID-19

The collaboration aims to develop novel, targeted treatments to address significant unmet needs

Coronavirus is said to be detected using Iceni Diagnostics’ rapid, point-of-care screening technology, which distinguishes it from influenza

Scientists say early data, generated with new NGS research panel from Thermo Fisher Scientific, suggest coronavirus is genetically stable, and could increase the effectiveness of vaccines in development

This critical appeal was made to the life sciences sector in order to tackle the spread of coronavirus

Hardy Diagnostics has announced the release of a rapid test for patients suspected of COVID-19 infection

Clinical laboratories can immediately begin using this kit to detect SARS-CoV-2

Sartorius supports the development of the first vaccine candidate against the novel coronavirus to enter clinical trials

AI-driven proteogenomic analysis company applies single-cell analysis expertise to develop treatments for COVID-19

Roche Group has provided an update on the various actions the company is taking to address the COVID-19 pandemic

The test will be used on the m2000 RealTime system that is currently available in hospitals and molecular laboratories in the U.S.

The panel covers entire genome of the new coronavirus to facilitate complete genome sequencing and support epidemiological studies

The company seeks quick clearance of the test through an FDA emergency use authorization

Chairman and CEO Albert Bourla calls on biopharma industry to collaborate on combating the global pandemic

The Standard is said to contain synthetic COVID-19 RNA transcripts and human genomic DNA

Researchers from the University of Oxford, UK, are developing rapid testing technology for COVID-19

The test kit aims to differentiate novel coronavirus from 21 other pathogens implicated in respiratory syndromes

IDT's primer and probe kit can be used as a component of the CDC testing protocol for the diagnosis and detection of COVID-19